XML 124 R60.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Hemophilia Spin-Off Hemophilia Spin-Off (Details Textual) - USD ($) $ in Millions | 3 Months Ended | 12 Months Ended |
--- | --- | --- | ---
Dec. 31, 2017 | Sep. 30, 2017 | Jun. 30, 2017 | Mar. 31, 2017 | Dec. 31, 2016 | Sep. 30, 2016 | Jun. 30, 2016 | Mar. 31, 2016 | Dec. 31, 2017 | Dec. 31, 2016 | Dec. 31, 2015 | Feb. 01, 2017
Assets and Liabilities Distributed to Bioverativ [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Other revenues | $ 179.6 | $ 48.8 | $ 41.6 | $ 90.0 | $ 50.9 | $ 98.6 | $ 79.0 | $ 87.9 | $ 360.0 | $ 316.4 | $ 236.1 |
Cost of sales |  |  |  |  |  |  |  |  | 1,630.0 | 1,478.7 | 1,240.4 |
Product, net | $ 2,712.4 | $ 2,622.5 | $ 2,639.7 | $ 2,380.1 | $ 2,502.9 | $ 2,539.6 | $ 2,466.0 | $ 2,309.4 | 10,354.7 | 9,817.9 | 9,188.5 |
Bioverativ |  |  |  |  |  |  |  |  |  |  |  |
Assets and Liabilities Distributed to Bioverativ [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Term of Bioverativ Transaction Services Agreement |  |  |  | 12 months |  |  |  |  |  |  |  |
Term of Bioverativ Manufacturing and Supply Agreement |  |  |  | 5 years |  |  |  |  |  |  |  |
Cash |  |  |  |  |  |  |  |  |  |  |  | $ 302.7
Other revenues |  |  |  |  |  |  |  |  | 64.8 |  |  |
Cost of sales |  |  |  |  |  |  |  |  | 15.1 |  |  |
Hemophilia Products |  |  |  |  |  |  |  |  |  |  |  |
Assets and Liabilities Distributed to Bioverativ [Line Items] |  |  |  |  |  |  |  |  |  |  |  |
Product, net |  |  |  |  |  |  |  |  | $ 74.4 | $ 846.9 | $ 554.2 |

X
- Definition Term of Bioverativ Manufacturing and Supply Agreement + References No definition available. + Details
Name: | biib_TermofBioverativManufacturingandSupplyAgreement
Namespace Prefix: | biib_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Term of Bioverativ Transaction Services Agreement + References No definition available. + Details
Name: | biib_TermofBioverativTransactionServicesAgreement
Namespace Prefix: | biib_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Total costs related to goods produced and sold during the reporting period. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_CostOfGoodsSold
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=84176398&loc=d3e2941-110230 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=65878427&loc=SL51721533-107759 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=65878427&loc=d3e1107-107759 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 5B -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=64827811&loc=SL51721673-107760 + Details
Name: | us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount, after sales adjustments, returns, allowances, and discounts, of revenue classified as other. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a),(d)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_OtherSalesRevenueNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Aggregate revenue during the period from the sale of goods in the normal course of business, after deducting returns, allowances and discounts. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(a)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_SalesRevenueGoodsNet
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=biib_BioverativMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ProductOrServiceAxis=biib_HemophiliaProductsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |